Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Rating of “Moderate Buy” by Brokerages

Tempus AI, Inc. (NASDAQ:TEM) has been assigned a consensus recommendation of “Moderate Buy” from the fourteen research firms that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have assigned a buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $68.6429.

TEM has been the topic of several recent analyst reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tempus AI in a research report on Thursday, January 22nd. Guggenheim dropped their target price on Tempus AI from $95.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, March 30th. Wall Street Zen cut Tempus AI from a “hold” rating to a “sell” rating in a research report on Saturday, February 28th. Jefferies Financial Group initiated coverage on Tempus AI in a research report on Monday, April 13th. They set an “underperform” rating and a $35.00 target price on the stock. Finally, Morgan Stanley dropped their target price on Tempus AI from $85.00 to $70.00 and set an “overweight” rating on the stock in a research report on Tuesday, March 3rd.

Insider Activity at Tempus AI

In other Tempus AI news, EVP Andrew Polovin sold 10,949 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $60.31, for a total transaction of $660,334.19. Following the transaction, the executive vice president owned 126,918 shares in the company, valued at approximately $7,654,424.58. The trade was a 7.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO James William Rogers sold 10,084 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $59.05, for a total transaction of $595,460.20. Following the transaction, the chief financial officer owned 101,166 shares in the company, valued at $5,973,852.30. The trade was a 9.06% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 563,471 shares of company stock worth $29,837,342 in the last three months. 24.26% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Victory Capital Management Inc. grew its position in Tempus AI by 1.5% during the third quarter. Victory Capital Management Inc. now owns 11,078 shares of the company’s stock worth $894,000 after buying an additional 162 shares during the period. Global Retirement Partners LLC grew its position in Tempus AI by 29.5% during the third quarter. Global Retirement Partners LLC now owns 733 shares of the company’s stock worth $59,000 after buying an additional 167 shares during the period. US Bancorp DE grew its position in Tempus AI by 6.6% during the third quarter. US Bancorp DE now owns 2,848 shares of the company’s stock worth $230,000 after buying an additional 176 shares during the period. Legacy Bridge LLC grew its position in Tempus AI by 1.6% during the fourth quarter. Legacy Bridge LLC now owns 12,418 shares of the company’s stock worth $733,000 after buying an additional 193 shares during the period. Finally, Truist Financial Corp grew its position in Tempus AI by 5.8% during the fourth quarter. Truist Financial Corp now owns 3,532 shares of the company’s stock worth $209,000 after buying an additional 194 shares during the period. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Price Performance

Shares of NASDAQ:TEM opened at $45.53 on Friday. Tempus AI has a one year low of $41.73 and a one year high of $104.32. The company has a debt-to-equity ratio of 2.96, a quick ratio of 3.15 and a current ratio of 3.31. The company has a 50-day simple moving average of $49.24 and a 200-day simple moving average of $59.98. The stock has a market capitalization of $8.18 billion, a price-to-earnings ratio of -26.47 and a beta of 3.99.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, May 5th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.08. Tempus AI had a negative net margin of 22.20% and a negative return on equity of 53.83%. The business had revenue of $348.12 million for the quarter, compared to analyst estimates of $345.44 million. During the same period in the previous year, the business posted ($0.24) earnings per share. The business’s revenue was up 36.1% compared to the same quarter last year. On average, analysts predict that Tempus AI will post -1.35 EPS for the current year.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.